Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors

Attanasio, 2009, Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review, Cardiol Rev, 17, 115, 10.1097/CRD.0b013e318199e9b7

Freedman, 2001, Therapeutic angiogenesis for ischemic cardiovascular disease, J Mol Cell Cardiol, 33, 379, 10.1006/jmcc.2000.1329

Losordo, 2004, Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies, Circulation, 109, 2692, 10.1161/01.CIR.0000128596.49339.05

Silva, 2007, Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis, J Thromb Haemost, 5, 590, 10.1111/j.1538-7836.2007.02386.x

Silva, 2010, Effects of VEGF temporal and spatial presentation on angiogenesis, Biomaterials, 31, 1235, 10.1016/j.biomaterials.2009.10.052

Carmeliet, 2000, Mechanisms of angiogenesis and arteriogenesis, Nat Med, 6, 389, 10.1038/74651

Jain, 2003, Molecular regulation of vessel maturation, Nat Med, 9, 685, 10.1038/nm0603-685

Chu, 2012, Therapeutic angiogenesis: controlled delivery of angiogenic factors, Ther Deliv, 3, 693, 10.4155/tde.12.50

Conway, 2001, Molecular mechanisms of blood vessel growth, Cardiovasc Res, 49, 507, 10.1016/S0008-6363(00)00281-9

Jain, 2001, Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy, Nat Med, 7, 987, 10.1038/nm0901-987

Vailhé, 2001, In vitro models of vasculogenesis and angiogenesis, Lab Invest, 81, 439, 10.1038/labinvest.3780252

Cao, 2010, Modulating notch signaling to enhance neovascularization and reperfusion in diabetic mice, Biomaterials, 31, 9048, 10.1016/j.biomaterials.2010.08.002

Cao, 2009, Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling, Biomaterials, 30, 4085, 10.1016/j.biomaterials.2009.04.051

Cao, 2007, Spatiotemporal control over growth factor signaling for therapeutic neovascularization, Adv Drug Deliv Rev, 59, 1340, 10.1016/j.addr.2007.08.012

Chen, 2007, Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation, Pharm Res, 24, 258, 10.1007/s11095-006-9173-4

Yung, 2009, Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells, Proc Natl Acad Sci U S A, 106, 15279, 10.1073/pnas.0905891106

Tremblay, 2005, In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue, J Pharmacol Exp Ther, 315, 510, 10.1124/jpet.105.089524

Clapp, 1993, The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis, Endocrinology, 133, 1292, 10.1210/endo.133.3.7689950

Yuen, 2010, Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones, Proc Natl Acad Sci U S A, 107, 17933, 10.1073/pnas.1001192107

Pelletier, 2000, An in vitro model for the study of human bone marrow angiogenesis: role of hematopoietic cytokines, Lab Invest, 80, 501, 10.1038/labinvest.3780056

Korff, 2001, Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness, FASEB J, 15, 447, 10.1096/fj.00-0139com

Orlidge, 1987, Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells, J Cell Biol, 105, 1455, 10.1083/jcb.105.3.1455

Hellström, 2001, Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis, J Cell Biol, 153, 543, 10.1083/jcb.153.3.543

Herman, 1985, Microvascular pericytes contain muscle and nonmuscle actins, J Cell Biol, 101, 43, 10.1083/jcb.101.1.43

Peppiatt, 2006, Bidirectional control of CNS capillary diameter by pericytes, Nature, 443, 700, 10.1038/nature05193

Yemisci, 2009, Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery, Nat Med, 15, 1031, 10.1038/nm.2022

Kutcher, 2009, The pericyte: cellular regulator of microvascular blood flow, Microvasc Res, 77, 235, 10.1016/j.mvr.2009.01.007

Antonelli-Orlidge, 1989, Influence of pericytes on capillary endothelial cell growth, Am Rev Respir Dis, 140, 1129, 10.1164/ajrccm/140.4.1129

Darland, 2003, Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival, Dev Biol, 264, 275, 10.1016/j.ydbio.2003.08.015

Song, 2005, PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival, Nat Cell Biol, 7, 870, 10.1038/ncb1288

Gerhardt, 2003, Endothelial-pericyte interactions in angiogenesis, Cell Tissue Res, 314, 15, 10.1007/s00441-003-0745-x

Borselli, 2010, Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors, Proc Natl Acad Sci U S A, 107, 3287, 10.1073/pnas.0903875106

Borselli, 2011, The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration, Biomaterials, 32, 8905, 10.1016/j.biomaterials.2011.08.019

Lutton, 2012, Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury, J Neurotrauma, 29, 957, 10.1089/neu.2010.1423

Reyes, 2012, Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect, Injury, 43, 334, 10.1016/j.injury.2011.10.008

Richardson, 2001, Polymeric system for dual growth factor delivery, Nat Biotechnol, 19, 1029, 10.1038/nbt1101-1029

Cao, 2003, Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2, Nat Med, 9, 604, 10.1038/nm848

Ferrara, 1999, Vascular endothelial growth factor: molecular and biological aspects, Curr Top Microbiol Immunol, 237, 1

Ferrara, 2000, VEGF: an update on biological and therapeutic aspects, Curr Opin Biotechnol, 11, 617, 10.1016/S0958-1669(00)00153-1

Davies, 2012, Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB, Tissue Eng Part A, 18, 26, 10.1089/ten.tea.2011.0192

Goel, 2011, Normalization of the vasculature for treatment of cancer and other diseases, Physiol Rev, 91, 1071, 10.1152/physrev.00038.2010

Darland, 1999, Blood vessel maturation: vascular development comes of age, J Clin Invest, 103, 157, 10.1172/JCI6127

Abramsson, 2003, Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors, J Clin Invest, 112, 1142, 10.1172/JCI200318549

Song, 2009, Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis, Cancer Res, 69, 6057, 10.1158/0008-5472.CAN-08-2007

Hellström, 1999, Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse, Development, 126, 3047, 10.1242/dev.126.14.3047

Davis, 1999, The angiopoietins: Yin and Yang in angiogenesis, Curr Top Microbiol Immunol, 237, 173

Gale, 1999, Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development, Genes Dev, 13, 1055, 10.1101/gad.13.9.1055

Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55

Greenberg, 2008, A role for VEGF as a negative regulator of pericyte function and vessel maturation, Nature, 456, 809, 10.1038/nature07424

Edelman, 1991, Controlled and modulated release of basic fibroblast growth factor, Biomaterials, 12, 619, 10.1016/0142-9612(91)90107-L

Gombotz, 1995, Biodegradable polymers for protein and peptide drug delivery, Bioconjug Chem, 6, 332, 10.1021/bc00034a002

Kuo, 1996, Novel systems for controlled delivery of macromolecules, Crit Rev Eukaryot Gene Expr, 6, 59, 10.1615/CritRevEukarGeneExpr.v6.i1.40

Langer, 1998, Drug delivery and targeting, Nature, 392, 5

Lee, 2000, Controlled growth factor release from synthetic extracellular matrices, Nature, 408, 998, 10.1038/35044106

Mahoney, 1999, Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain, Proc Natl Acad Sci U S A, 96, 4536, 10.1073/pnas.96.8.4536

Murray, 1984, Controlled release of microquantities of macromolecules, Cancer Drug Deliv, 1, 119, 10.1089/cdd.1984.1.119

Peirce, 2004, Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1, Am J Physiol Heart Circ Physiol, 286, 25, 10.1152/ajpheart.00833.2003

Ennett, 2006, Temporally regulated delivery of VEGF in vitro and in vivo, J Biomed Mater Res A, 79, 176, 10.1002/jbm.a.30771

Benjamin, 1998, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF, Development, 125, 1591, 10.1242/dev.125.9.1591

Roviezzo, 2005, Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage, J Pharmacol Exp Ther, 314, 738, 10.1124/jpet.105.086553

Scharpfenecker, 2005, The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism, J Cell Sci, 118, 771, 10.1242/jcs.01653

Yoshiji, 2005, Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice, Gut, 54, 1768, 10.1136/gut.2005.067900

Hori, 2004, A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro, J Neurochem, 89, 503, 10.1111/j.1471-4159.2004.02343.x

Sundberg, 2002, Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo, Lab Invest, 82, 387, 10.1038/labinvest.3780433

Uemura, 2002, Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells, J Clin Invest, 110, 1619, 10.1172/JCI0215621